The extensive use of biotech, which spans various fields, with significant impacts on healthcare, agriculture, and industrial processes, coupled with numerous technological advances, positions the biotechnology industry for considerable growth and expansion.
Given the industry’s steady growth prospects, investors could buy A-rated biotech stocks Entrada Therapeutics, Inc. (TRDA), Exelixis, Inc. (EXEL), and Gilead Sciences, Inc. (GILD) for long-term gain. These stocks are rated A (Strong Buy) in our POWR Ratings system.
